FIELD: medicine.
SUBSTANCE: according to the invention, the pharmaceutical composition contains 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1H-1,2,4-triazole-1-yl]-1H-pyrrole[2,3-c]pyridine-3-yl]-1,2-dioxo-etyl]piperazine (compound 1) and another agent used for treating AIDS or HIV infection, chosen of inhibitor CCR5 - Sch-C, inhibitor CXCR4 - AMD-3100 and HIV integrase inhibitor BMS-538203.
EFFECT: improved antiviral activity.
7 tbl
Authors
Dates
2009-09-20—Published
2005-03-01—Filed